HIV gp120 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern).
D016915:AIDS Vaccines / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D004279:DNA, Viral / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D015316:Genetic Therapy; D015699:HIV Envelope Protein gp120 / Q000009:adverse effects* / Q000235:genetics; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D019444:Vaccines, DNA / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*
D016915:AIDS Vaccines; D004279:DNA, Viral; D015507:Drugs, Investigational; D015699:HIV Envelope Protein gp120; D019444:Vaccines, DNA